BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 19665424)

  • 1. Spectral characteristics of tramadol in different solvents and beta-cyclodextrin.
    Anton Smith A; Manavalan R; Kannan K; Rajendiran N
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Oct; 74(2):469-77. PubMed ID: 19665424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual fluorescence of N-phenylanthranilic acid: Effect of solvents, pH and beta-cyclodextrin.
    Rajendiran N; Balasubramanian T
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Nov; 68(3):867-76. PubMed ID: 17433768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual fluorescence of syringaldazine.
    Rajendiran N; Balasubramanian T
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Nov; 68(3):894-904. PubMed ID: 17317290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-guest interaction of L-tyrosine with beta-cyclodextrin.
    Shanmugam M; Ramesh D; Nagalakshmi V; Kavitha R; Rajamohan R; Stalin T
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):125-32. PubMed ID: 18243779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral and electrochemical study of host-guest inclusion complex between 2,4-dinitrophenol and β-cyclodextrin.
    Srinivasan K; Stalin T; Sivakumar K
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Aug; 94():89-100. PubMed ID: 22516119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
    Yuexian F; Junfen L; Chuan D
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C; Zoppi A; Genovese D; Longhi M
    Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
    Garnero C; Longhi M
    J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excimer formation in inclusion complexes of β-cyclodextrin with salbutamol, sotalol and atenolol: spectral and molecular modeling studies.
    Antony Muthu Prabhu A; Subramanian VK; Rajendiran N
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():95-107. PubMed ID: 22659277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY; Hsu CH; Sheu MT
    J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-guest inclusion complex of propafenone hydrochloride with α- and β-cyclodextrins: spectral and molecular modeling studies.
    Siva S; Thulasidhasan J; Rajendiran N
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():559-67. PubMed ID: 23872014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin.
    Sun DZ; Li L; Qiu XM; Liu F; Yin BL
    Int J Pharm; 2006 Jun; 316(1-2):7-13. PubMed ID: 16554127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorimetric and prototropic studies on the inclusion complexation of 3,3'-diaminodiphenylsulphone with beta-cyclodextrin and its unusual behavior.
    Enoch MV; Rajamohan R; Swaminathan M
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Oct; 77(2):473-7. PubMed ID: 20634124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
    El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence enhancement of 1-napthol-5-sulfonate by forming inclusion complex with beta-cyclodextrin in aqueous solution.
    Abdel-Shafi AA; Al-Shihry SS
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Apr; 72(3):533-7. PubMed ID: 19091626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and study on the solid inclusion complex of cloxacillin sodium with beta-cyclodextrin.
    Chao JB; Zhang BT
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Sep; 68(1):108-12. PubMed ID: 17321790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual spectral shifts on fast violet-B and benzanilide: Effect of solvents, pH and beta-cyclodextin.
    Antony Muthu Prabhu A; Sankaranarayanan RK; Siva S; Rajendiran N
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Oct; 74(2):484-97. PubMed ID: 19628426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.